Proguanil
| File:Proguanil.svg | |
| Gene therapy | |
|---|---|
| Clinical data | |
| ATC code | |
| Physiological data | |
| Legal status | |
| Pharmacokinetic data | |
| Elimination half-life | ~20 h |
| Identifiers | |
| |
| CAS Number | |
| PubChem Template:Abbreviation | |
| DrugBank | |
| Chemical and physical data | |
| Formula | C11H16ClN5 |
| Molar mass | 253.731 g/mol |
Proguanil (proguanil hydrochloride) is a prophylactic antimalarial drug, which works by stopping the malaria parasite, Plasmodium falciparum and Plasmodium vivax, from reproducing once it is in the red blood cells. It does this by inhibiting the enzyme, dihydrofolate reductase, which is involved in the reproduction of the parasite.
Proguanil is effective against sporozoites.
Proguanil is usually taken in combination with another anti-malarial drug such as atovaquone (e.g., in the drug Malarone) or chloroquine. Malarone has fewer side effects than mefloquine, but can be more expensive because it's taken daily. Proguanil is taken with Atovaquone for chloroquine-resistant and multidrug resistant strains of P. falciparum and P. vivax.
Proguanil also known as Paludrine (Astra Zeneca)
References
- Articles with short description
- Pages with broken file links
- Infobox-drug molecular-weight unexpected-character
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Antimicrobial stubs
- Dihydrofolate reductase inhibitors
- Antimalarial agents